CELLSEARCH® Circulating Tumor Cell Test in metastatic colorectal cancer (mCRC)—clinical trials and real-world case studies
Pivotal Clinical Trial—Circulating tumor cells (CTCs) as a predictive marker of tumor response, progression-free survival, and overall survival (OS) in patients with mCRC1,2
CTCs were monitored in 430 mCRC patients at baseline and after starting 1st, 2nd, or 3rd line therapy.1
- Cohen SJ, Punt CJA, Iannotti N, et al. J Clin Oncol. 2008;26(19):3213-3221.
- CELLSEARCH® Circulating Tumor Cell Kit (Epithelial) Instructions for Use. Menarini Silicon Biosystems Inc.